http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102793882-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4cdc80ea7f9847e29982e2483ec8ace |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9062 |
| filingDate | 2012-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_862c362df60ed7602177c4a1f7e3535d |
| publicationDate | 2013-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102793882-B |
| titleOfInvention | Traditional Chinese medicine for treatment of myasthenia gravis |
| abstract | The invention relates to a traditional Chinese medicine for treatment of myasthenia gravis, and is characterized by being prepared by the following raw medicinal materials by weight: 1 part of storax, 12 parts of white atractylodes rhizome, 6 parts of rhodiola rosea, 8 parts of exocarpium citri rubrum, 9 parts of alpinia oxyphylla, 12 parts of prepared rehmannia root, 8 parts of dodder, and 20 parts of coriolus versicolor. Clinical studies prove that the traditional Chinese medicine can safely and effectively treat myasthenia gravis. |
| priorityDate | 2012-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453398165 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7550 |
Total number of triples: 14.